Bayer AG (LTS:0P6S)
€ 48.69 +1.0133 (+2.13%) Market Cap: 47.40 Bil Enterprise Value: 76.12 Bil PE Ratio: 0 PB Ratio: 1.62 GF Score: 55/100

Bayer AG to Share the Background and First Assessments of OCEANIC-AF Trial Presentation Transcript

Nov 21, 2023 / 01:00PM GMT
Release Date Price: €34 (-0.09%)

Nov 21, 2023 / 01:00PM GMT
Presentation
Nov 21, 2023 / 01:00PM GMT

=====================
Corporate Participants
=====================
* Christian Rommel
Bayer Aktiengesellschaft - Head of Research & Development at Pharmaceuticals Division
* Jost Reinhard
Bayer Aktiengesellschaft - Head of IR
* Stefan Oelrich
Bayer Aktiengesellschaft - Head of the Pharmaceuticals Division & Member of the Board of Management
* William N. Anderson
Bayer Aktiengesellschaft - Chairman of the Management Board & CEO
* Wolfgang U. Nickl
Bayer Aktiengesellschaft - CFO & Member of Management Board

=====================
Conference Call Participants
=====================
* Alycia Samsudin
* Charles Bentley
Jefferies LLC, Research Division - Equity Analyst
* Damien Conover
Morningstar Inc., Research Division - Sector Director and Equities Strategist
* Gunther Zechmann
Sanford C. Bernstein & Co., LLC., Research Division - Research Analyst
* Peter Verdult
Citigroup Inc.,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot